-+ 0.00%
-+ 0.00%
-+ 0.00%

Samsung Biologics CEO John Rim Adds 10 Subscription Rights, Shareholding Unchanged

PUBT·10/26/2026 07:14:54
Listen to the news
Samsung Biologics CEO John Rim Adds 10 Subscription Rights, Shareholding Unchanged
  • Samsung Biologics CEO Rim JohnChongbo received 10 subscription rights certificates on October 19, 2026.
  • Total securities holdings rose to 270 as of October 26, 2026; shareholdings remained unchanged at 260 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samsung Biologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261026000214), on October 26, 2026, and is solely responsible for the information contained therein.